In humans, the loss of function of UGP2 caused a genetic disease (Roeben et al., 2006), and the UGP2 expression was correlated with clinicopathological and biological behaviors, which could be used as a biomarker for progression and poor prognosis of gallbladder cancer (Wang et al., 2016). The gene discussed is UGP2; the disease is hereditary disease.